Tweet
Looking at the SNP's in Clinvar, for example http://www.ncbi.nlm.nih.gov/clinvar/variation/11/, I see that the SNP NM_000410.3(HFE):c.193A>T (p.Ser65Cys) (also known as rs1800730) corresponds to the disease hemochromatosis. Since we have 2 alleles, that means the genotype possibilities are AA, AT, or TT. From the ClinVar data, is it possible to see which genotype are associated with the disease? I assume that since we have a A to T mutation, then T must be the pathogenic allele. So, does this mean TT is worse than AT which is worse than AA?
-
Last edited by leontp587; 11-18-2014, 01:37 PM. -
I have the same question. Could anyone can explain?Originally posted by leontp587 View Post -
Hello,
whether AT or TT is needed to be pathogenic depends on the mode of inheritance. Is it dominant than it is enough if one allele has T, if it is recessive you need TT (or a second mutation in the gene on the other allele).
In clinvar you find under "Condition(s)" links to OMIM, where you can read about the inheritance.
fin swimmerComment
-
You may also want to expand the text in "Summary evidence" (on the Illumina and Invitae rows).Comment
-
Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...Today, 01:13 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment